Folotyn

DRUG2 trials

Sponsors

Acrotech Biopharma Inc.

Conditions

Non Hodgkin's LymphomaNon-Small Cell Lung Cancer

Phase 1

Phase 1 Study of Fusilev to Prevent or Reduce Mucositis in Patients With Non-Hodgkin's Lymphoma Receiving Folotyn

WithdrawnNCT01789723

Acrotech Biopharma Inc.Non Hodgkin's Lymphoma

Start: 2013-03-31End: 2015-03-31Updated: 2020-01-23

Phase 1 Study of Fusilev® to Prevent or Reduce Mucositis in Patients With Non-Small Cell Lung Cancer Receiving Folotyn®

WithdrawnNCT01820091

Acrotech Biopharma Inc.Non-Small Cell Lung Cancer

Start: 2013-04-30End: 2015-04-30Updated: 2020-01-23